• News
  • BioTech

Althea Tech, Profectus BioSciences sign manufacturing agreement

Althea Technologies Inc., a provider of biopharmaceutical development and manufacturing services, and Profectus BioSciences Inc., a technology based vaccine company, signed a manufacturing supply agreement for plasmid DNA production.

Under the agreement, Althea will provide gram-scale quantities of cGMP (current good manufacturing practice) manufactured plasmid DNA expressing IL-12 to assist Profectus Biosciences' ongoing DNA vaccine development efforts, which are supported by a contract from the National Institutes of Health.

IL-12 helps prompt an immune response once the DNA enters a cell, which is part of Profectus Biosciences' technology platform designed to overcome the poor delivery and immunogenicity of many DNA vaccines.


2013 Top Influentials: Magda Marquet, Althea Technologies co-founder

User Response
0 UserComments